YI-WEN MA: Open Payments
NPI 1790406759 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 16 payments from 10 companies in 2025. Trend: 2023 $138 · 2024 $22 · 2025 $504
Food & beverage: $454Education: $50
| Company | Payments | Amount |
|---|---|---|
| Legend Biotech USA Inc. | 1 | $117 |
| ABBVIE INC. | 3 | $98 |
| GENZYME CORPORATION | 3 | $89 |
| SANOFI-AVENTIS U.S. LLC | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 2 | $37 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Adaptive Biotechnologies Corporation | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Incyte Corporation | 1 | $15 |
Products named: CARVYKTI, SARCLISA, IMBRUVICA, REZUROCK, LYNOZYFIC, SYLVANT, SCEMBLIX, EPKINLY.
Industry payments across NY — which companies pay providers there.
